8-K/A

AMENDED CURRENT REPORT

Company: TENAX THERAPEUTICS, INC.
Filed: November 8, 2019
Period of Report: June 13, 2019
Accession Number: 0001654954-19-012565

View Document ↗ View on SEC.gov ↗